• Keine Ergebnisse gefunden

Journal name:

N/A
N/A
Protected

Academic year: 2022

Aktie "Journal name:"

Copied!
4
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

Journal name: Archives of Virology

Title: Bovine Coronavirus Infections in Turkey: Molecular Analysis of the Full-Length Spike Gene Sequences of Viruses From Digestive and Respiratory Infections

Authors:

Secil Sevinc Temizkan

*a

, Feray Alkan

a,b

a

Ankara University, Graduate School of Health Sciences, Department of Virology, Ankara, TURKEY

b

Ankara University, Faculty of Veterinary Medicine, Department of Virology, Ankara, Turkey.

*Corresponding Author: Secil Sevinc Temizkan

Ankara University, Faculty of Veterinary Medicine, Department of Virology, Diskapi, 06110, Ankara, Turkey.

E-mail: sevinc@ankara.edu.tr Phone: +90 553 085 36 26

Supplement 1: Information about the samples used in this study.

City Sampling Date

Number of

samples Ages of Animals Samples Species

Clinical Signs

Ankara

2001 2 Faeces Diarrhea

2014 1 7 d Faeces Diarrhea

2017 3 2-4 m Nasal discharge Nasaldischarge, cough

2018 9

15 d Nasal discharge Nasaldischarge, cough

2018 4 8 m Nasal discharge Nasaldischarge, cough

2019 5 Nasal discharge Nasal discharge, dyspnea

2018 4 8 m Nasal discharge Nasaldischarge, cough

2019 7 15 d Nasal discharge Nasaldischarge, cough, depression

Aksaray 2005 3 Faeces Diarrhea, dehydration

2006 2 11-14 d Faeces Diarrhea

2008 2 5-15 d Faeces Diarrhea

Eskisehir 2006 3 15-20 d Faeces Diarrhea

2006 1 15 d Nasaldischarge Nasaldischarge, cough

Kars 2006 3 Faeces Diarrhea, dehydration

Van 2006 2 Faeces Diarrhea

Kirklareli 2011 1 70 d Faeces Diarrhea, anorexia

1

(2)

Erzurum 2014 2 2 y Nasal discharge Nasaldischarge, cough

2017 3 1 m Faeces Diarrhea

S. Urfa 2014 3 8-10 d Faeces Diarrhea, dehydration

Amasya 2015 2 4 d Faeces Diarrhea

Cankiri 2016 1 5 d Faeces Diarrhea, dehydration

Izmir

2013 1 14 d Faeces Diarrhea, dehydration

2015 2 15 d Faeces Diarrhea

2017 4 4 y Nasal discharge Nasaldischarge

2018 1 15 d Faeces Diarrhea

2018 3

5

y Nasal discharge Nasaldischarge

2019 2 15 d Nasal discharge Nasaldischarge, cough

Denizli 2017 5 7-30 d Nasal discharge Nasaldischarge, cough, anorexia

2017 9 7 d- 15 m Faeces Diarrhea, anorexia, dehydration

Burdur 2019 5 1,5- 9 m Nasal discharge Nasaldischarge

2019 5 1- 1,5 y Nasal discharge Nasaldischarge, cough

Hatay 2019 4 Nasal discharge Nasaldischarge, cough, dyspnea

Tokat 2018 5 15 d-8 m Nasal discharge Nasaldischarge, cough

2019 10

45-90 d Nasal discharge Nasaldischarge, cough

d:day; m:month; y: year

Supplement 2: The primer pairs used in this study.

Primer Name

Primer Sequence (5’→3’)

Location Target Gene Region

Annealing (°C)

Amplicon

Size References BCoV

N-F

GCAATCCAGTAGTAGAGCGT 21-40

N (first

round) 50°C 730 bp

(17) BCoV

N-R

CTTAGTGGCATCCTTGCCAA 731-750 nBCoV

N-F

GCCGATCAGTCCGACCAATG 79-98

N(second

round) 58°C 407 bp

nBCoV

N-R AGAATGTCAGCCGGGGTAG 467-485

S-AF ATGTTTTTGATACTTTTAATT 1-21

S-1 51°C 655bp

(18)

S-AR AGTACCACCTTCTTGATAAA 654-635

S-BF ATGGCATTGGGATACAG 549-565

S-1 55°C 490 bp

S-BR TAATGGAGAGGGCACCGACTT 1039-1018

S-CF GGGTTACACCTCTCACTTCT 782-801

S-1 58°C 769bp

S-CR GCAGGACAAGTGCCTATACC 1550-1531 S-DF GTCCGTGTAAATTGGATGGG 1460-1479

S-1 55°C 827bp

S-DR TGTAGAGTAATCCACACAGT 2286-2267

S-EF TTACAAAAATCAAACACAGACAT 1855-1877 S-1 S-2 55°C 877bp S-ER AAACTTTATTACAATCGCTTCC 2731-2710

S-FF TCAATTTTTCCCCTGTATTAGG 2680-2702

S-2 55°C 555 bp

(6) S-FR CMAGTCTRGATAGAATTTCTTGTAA 3234-3209

S-GF GCTACCAATTCTGCTTTAGTTA 3099-3121

S-2 55°C 519 bp

S-GR GTAGTAATAACCACTACCAGTG 3617-3595 S-HF TTTAGCTATGTCCCTACTAAGTA 3475-3498

2

(3)

S-2 58°C 637 bp S-HR CCAATAAATCAAAGACGAACTTA 4112-4089

S-1F GTTTCTGTTAGCAGGTTTAA 1329-1348

S-1 55°C 488 bp (1)

S-1R ATATTACACCTATCCCCTTG 1797-1816

Supplement 3: The strains used in the phylogenetic tree for S gene sequences.

Strain/isolate name Sample type GenBank accession no. Source BCoV/Turkey/H1/2013 Faecal MK989633-34

This study

BCoV/Turkey/U1/2014 Faecal MK989622

BCoV/Turkey/4950/2015 Faecal MK989620 BCoV/Turkey/4945/2015 Faecal MK989621 BCoV/Turkey/G76/2015 Faecal MK989628-29 BCoV/Turkey/G83/2015 Faecal MK989630-32 BCoV/Turkey/8553/2015 Faecal MK989626

BCoV/Turkey/S8/2017 Nasal MK989624

BCoV/Turkey/T5/2018 Nasal MK989623

BCoV/Turkey/79/2018 Nasal MK989627

BCoV/Turkey/1N/2019 Nasal MK989625

BCoV/Turkey/AN4/2005 Faecal GQ259978

National Center for Biotechnology Information BCoV/Turkey/AN11/2005 Faecal GQ259979

BCoV/USA/LY138/1965 Faecal AF058942 (LY138) BCoV/USA/Mebus/1971 Faecal U00735 (Mebus)

BCoV/USA/ENT/1998 Faecal AF391541

BCoV/USA/E-AH65/2001 Faecal EF424615

BCoV/USA/7-16-23/2016 Faecal MH043955 BCoV/China/HLJ-14/2015 Faecal KM985631 BCoV/Denmark/05-2/2005 Faecal KF169917

BCoV/France/-/1979 Faecal D00731

BCoV/South Korea/KCD10/2007 Faecal DQ389641 BCoV/Sweden/C-92/1992 Faecal KF169908 BCoV/Italy/339-06/2006 Faecal EF445634 BCoV/Japan/ Kakegawa/1976 Faecal AB354579 BCoV/Vietnam/PL84/2017 Faecal MH197037 BCoV/Germany/G95/1989 Nasaldischarge M80844

BCoV/USA/LSU/1994 Nasal discharge AF058943 BCoV/USA/LUN/1998 Nasal discharge AF391542 BCoV/Denmark/05-3/2005 Nasal discharge KF169918 BCoV/France/EPI-Caen-01/2005 Nasal discharge KT318111 BCoV/South Korea/KWD1/2005 Nasal discharge AY935637 BCoV/Sweden/U-09-3/2009 Nasal discharge KF169936 BCoV/Italy/438-06-TN/2008 Nasal discharge EU814647

BCoV/Germany/V270/1983 - EF193075

BCoV/USA/DB2/1984 - DQ811784

BCoV Norden Vaccine Vaccine strain M64668

HCoV/OC43/2020 - NC006213.1

3

(4)

Supplement 4: N gene gel electrophoresis results: BCoV Nested-RT-PCR 2nd round result gel image [M: DNA ladder (100 bp), 1-9: Examples, 10: Positive Control (407 bp), 11: Negative Control].

Supplement 5: S gene gel electrophoresis results: RT-PCR gel images (M: DNA ladder, 100 bp) Various primer pairs were used for the S gene amplification (4,112 bp).

A. Primary SA: [2-11: Samples, 1: Positive Control (655 bp), 12: Negative Control]

B. Primary SB: [2-4: Samples, 1: Positive Control (490 bp), 5: Negative Control]

C. Primary SC: [2-5: Samples, 6: Positive Control (769 bp), 1: Negative Control]

D. Primary SD: [2-6: Samples, 1: Positive Control (827 bp), 7: Negative Control]

E. Primary SE: [2-5: Samples, 6: Positive Control (877 bp), 1: Negative Control]

F. Primary SF: [2-5: Samples, 1: Positive Control (555 bp), 6: Negative Control]

G. Primary SG: [1-2: Samples, 3: Positive Control (519 bp), 4: Negative Control]

H. Primary SH: [2-4: Samples, 1: Positive Control (637 bp), 5: Negative Control]

I. Primary S1: [1-6: Samples, 7: Positive Control (488 bp), 8: Negative Control]

4

Referenzen

ÄHNLICHE DOKUMENTE

The objectives: The main objective of this PhD thesis was to determine the burden and the association of HIV, helminth and respiratory pathogens (viruses and bacteria)

Risk factors for Plasmodium falciparum and Plasmodium vivax gametocyte carriage in Papua New Guinean children with uncomplicated malaria. Malaria morbidity in Papua Indonesia, an

In Chapter 5, newly-generated complete genome sequence information of the dengue virus were utilised to provide a historical account of the virus diversity in Malaysia since

Schelling et al. Delafosse et al. investigated the prevalence of BTB in cattle herds of the Abéché region and reported a positive reaction to bovine tuberculin in 1% of the

Allowing for the fact that many infected people have multiple parasite clones, it was estimated that untreated Plasmodium falciparum infections in asymptomatic

In Chad, during a study of two years on tuberculosis in humans and animals, numerous Mycobacterium tuberculosis complex (MTC) and NTM isolates were obtained. The purpose

Risk factors for nosocomial primary bloodstream infection in pediatric intensive care unit patients: a 2-year prospective cohort study.. Infect Control

The sialic acids can act as receptor determinants for the HA protein of influenza viruses and mediate the binding of bacteria to viral glycoproteins exposed on the surface